Featured Research

from universities, journals, and other organizations

Combined RB and PTEN loss identifies DCIS primed for invasive breast cancer

Date:
November 28, 2012
Source:
Journal of the National Cancer Institute
Summary:
The combined loss of two tumor suppressor genes, retinoblastoma and phosphatase and tensin homolog was shown to be strongly associated with progression of DCIS to invasive breast cancer, according to a new study.

The combined loss of two tumor suppressor genes, retinoblastoma (RB) and phosphatase and tensin homolog (PTEN) was shown to be strongly associated with progression of DCIS to invasive breast cancer, according to a study published November 28 in the Journal of the National Cancer Institute.

Ductal carcinoma in situ (DCIS) is a breast cancer precursor lesion for which there are no established markers defining risk of progression to invasive breast cancer. As a result, the majority of women are treated uniformly with surgery and radiation therapy potentially with additional hormonal therapy. However, only a subset of DCIS patients are at risk for developing potentially life-threatening invasive breast cancer requiring such treatment. Thus, defining these patients is a high priority for improving patient care by more effectively directing treatment of DCIS.

Dr. Agnieszka Witkiewicz, Department of Pathology at the University of Texas, Southwestern, and colleagues, assessed RB and PTEN expression in the tissue from over 200 DCIS patients who were treated by surgical resection. They analyzed the association of the loss of each tumor suppressor with DCIS recurrence and progression to invasive breast cancer and conducted functional studies of the two tumor suppressors in cell line models.

About one-third of the women in the study had either recurrence of DCIS or progression to invasive disease and RB loss was statistically significantly associated with recurrent DCIS. Although PTEN loss was not independently associated with clinical outcome, in combination with RB loss, PTEN deficiency defined DCIS cases that were at substantially increased risk for recurrence and progression. Women with DCIS lacking both RB and PTEN were over 5 times as likely to develop invasive breast cancer. Cellular studies demonstrated that each gene plays a distinct role in facilitating aberrant proliferation and invasive properties that contribute to disease progression.

Dr. Erik Knudsen, an author on the study, concluded that "RB and PTEN together have prognostic utility that could be used to define those DCIS cases that need to be treated aggressively." The authors note, however, that these findings are from only one cohort treated solely by surgery and therefore must be replicated in other cohorts and with additional therapeutic interventions such as radiation. Dr. Witkiewicz believes that, "Such planned studies will be particularly informative for providing a means to spare women from unnecessary radiation exposure and improve the care of women with DCIS." Dr. Knudsen also says, "Interventions exploiting tumor suppressor loss could be utilized to more effectively treat high-risk DCIS." The authors believe that such work will lead to a personalized/rational approach to the treatment of DCIS replacing the current "one size fits all" treatment.


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Journal Reference:

  1. Erik S. Knudsen, Thomas F. Pajak, Maria Qeenan, A. Kathleen McClendon, Benjamin D. Armon, Gordon F. Schwartz, and Agnieszka K. Witkiewicz. Retinoblastoma and Phosphate and Tensin Homolog Tumor Suppressors: Impact on Ductal Carcinoma In Situ Progression. J Natl Cancer Inst, November 28, 2012 DOI: 10.1093/jnci/djs446

Cite This Page:

Journal of the National Cancer Institute. "Combined RB and PTEN loss identifies DCIS primed for invasive breast cancer." ScienceDaily. ScienceDaily, 28 November 2012. <www.sciencedaily.com/releases/2012/11/121128162205.htm>.
Journal of the National Cancer Institute. (2012, November 28). Combined RB and PTEN loss identifies DCIS primed for invasive breast cancer. ScienceDaily. Retrieved April 18, 2014 from www.sciencedaily.com/releases/2012/11/121128162205.htm
Journal of the National Cancer Institute. "Combined RB and PTEN loss identifies DCIS primed for invasive breast cancer." ScienceDaily. www.sciencedaily.com/releases/2012/11/121128162205.htm (accessed April 18, 2014).

Share This



More Health & Medicine News

Friday, April 18, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Scientists Create Stem Cells From Adult Skin Cells

Scientists Create Stem Cells From Adult Skin Cells

Newsy (Apr. 17, 2014) The breakthrough could mean a cure for some serious diseases and even the possibility of human cloning, but it's all still a way off. Video provided by Newsy
Powered by NewsLook.com
Obama: 8 Million Healthcare Signups

Obama: 8 Million Healthcare Signups

AP (Apr. 17, 2014) President Barack Obama gave a briefing Thursday announcing 8 million people have signed up under the Affordable Care Act. He blasted continued Republican efforts to repeal the law. (April 17) Video provided by AP
Powered by NewsLook.com
Is Apathy A Sign Of A Shrinking Brain?

Is Apathy A Sign Of A Shrinking Brain?

Newsy (Apr. 17, 2014) A recent study links apathetic feelings to a smaller brain. Researchers say the results indicate a need for apathy screening for at-risk seniors. Video provided by Newsy
Powered by NewsLook.com
Could Even Casual Marijuana Use Alter Your Brain?

Could Even Casual Marijuana Use Alter Your Brain?

Newsy (Apr. 16, 2014) A new study conducted by researchers at Northwestern and Harvard suggests even casual marijuana use can alter your brain. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins